Korio

Doylestown, United States

Korio is a RTSM platform that provides solutions to tackle clinical trial challenges.

$5.5M raised

Sep 2024

Series A

Top Investors

BIP VenturesExcelerate Health VenturesBoston Millennia Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Korio raised?

Korio has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in September 2024.

Who are Korio's investors?

Korio's investors include BIP Ventures, Excelerate Health Ventures, Boston Millennia Partners.

Where is Korio headquartered?

Korio is headquartered in Doylestown, United States.

What does Korio do?

Korio is a RTSM platform that provides solutions to tackle clinical trial challenges.

What stage is Korio at?

Korio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 10, 2024.

MLA

"Korio — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/korio. Accessed June 10, 2026.

APA

VCBacked. (2024). Korio — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/korio

Wikipedia (cite web)

{{cite web |title=Korio — Funding & Investors |url=https://www.vcbacked.co/company/korio |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 10, 2024.